Revelation Biosciences- Units (1 Ord share & 1 War) Operating Income

As of the most recent data (June 2026), REVBU shows a operating income of $-9.1B. That compares with $-8.1M in the prior-year period — down 111818.7% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, REVBU's operating income is now $-9.1B (was $-8.1M) — a 111818.7% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Revelation Biosciences- Units (1 Ord share & 1 War) is outperforming or lagging.

Tracking REVBU's operating income over time shows whether Revelation Biosciences- Units (1 Ord share & 1 War) is scaling, shrinking, or reshaping that part of the business. The current reading is $-9.1B That compares with $-8.1M in the prior-year period — down 111818.7% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this operating income page, Stockcircle has Revelation Biosciences- Units (1 Ord share & 1 War)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect operating income (currently $-9.1B) with ownership activity and broader fundamentals.